Your Health Matters

Actions

Alzheimer's drug may not have followed standard FDA procedures

Alzheimer Drug
Posted

(KERO) — The approval of an Alzheimer's treatment may not have followed standard approval procedures.

An 18-month investigation by the House Oversight and Reform Committee found "atypical collaboration and interactions" between the Food and Drug Administration (FDA) and the drug's manufacturer, Biogen.

Investigators switched to consider the drug under its Accelerated Approval Program. This allows the FDA to approve certain drugs that both meet "an unmet medical need" and "treat serious conditions."

Investigators found during that process, FDA and Biogen officials communicated more than 115 times, which the investigation report says the FDA admitted "exceeded the norm in some respects."



,

Weather

Daily Forecast

View Hourly Forecast

Day

Conditions

HI / LO

Precip

Friday

06/13/2025

Clear

-° / 65°

0%

Saturday

06/14/2025

Clear

96° / 65°

0%

Sunday

06/15/2025

Clear

98° / 66°

0%

Monday

06/16/2025

Clear

97° / 66°

0%

Tuesday

06/17/2025

Clear

96° / 68°

0%

Wednesday

06/18/2025

Clear

100° / 72°

0%

Thursday

06/19/2025

Clear

100° / 66°

0%

Friday

06/20/2025

Clear

92° / 60°

0%